TY - JOUR T1 - The economic value of quarantine is higher at lower case prevalence, with quarantine justified at lower risk of infection JF - medRxiv DO - 10.1101/2020.11.24.20238204 SP - 2020.11.24.20238204 AU - James Petrie AU - Joanna Masel Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/03/2020.11.24.20238204.abstract N2 - Some infectious diseases, such as COVID-19, are so harmful that they justify broad scale social distancing. Targeted quarantine can reduce the amount of indiscriminate social distancing needed to control transmission. Finding the optimal balance between targeted vs. broad scale policies can be operationalized by minimizing the total amount of social isolation needed to achieve a target reproductive number. Optimality is achieved by quarantining on the basis of a risk threshold that depends strongly on current disease prevalence, suggesting that very different disease control policies should be used at different times or places. Aggressive quarantine is warranted given low disease prevalence, while populations with a higher base rate of infection should rely more on social distancing by all. The total value of a quarantine policy rises as case counts fall, is relatively insensitive to vaccination unless the vaccinated are exempt from distancing policies, and is substantially increased by the availability of modestly more information about individual risk of infectiousness.Competing Interest StatementJoanna Masel consults for WeHealth, who distribute exposure notification solutions to Arizona and Bermuda. James Petrie is likely to soon sign a contract giving him an equity interest in WeHealth.Funding StatementJames Petrie received funding from the Ontario Graduate Scholarship and the University of Waterloo.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA ER -